|
|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$213,523
|
N/A
|
National Cancer Institute
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
2U10CA107868-07
|
$235,766
|
$9,431
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$1,832,019
|
$183,202
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$143,853
|
$71,926
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
2P01CA078378-11A2
|
$2,056,275
|
$2,056,275
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
|
SPORE in Myeloma
|
5P50CA100707-08
|
$2,300,000
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-18
|
$287,403
|
$287,403
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183 00560
|
$113,406
|
$5,670
|
Anderson, William
|
DCEG (NCI)
|
|
|
Protein regulation in multiple myeloma
|
ZIA BC 011312
|
$97,551
|
$97,551
|
Annunziata, Christina
|
CCR (NCI)
|
|
|
Southeast Cancer Control Consortium, Inc
|
2U10CA045808-24
|
$2,264,660
|
$22,647
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-12
|
$104,956
|
$4,198
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Eastern Cooperative Oncology Group Studies
|
2U10CA014548-36
|
$420,754
|
$16,830
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-20
|
$252,182
|
$5,044
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
|
Southwest Oncology Group Treatment Grant
|
2U10CA032102-31
|
$10,205,783
|
$612,347
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-31S2
|
$1,500,000
|
$90,000
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Tumor Banking for the Southwest Oncology Group
|
3U24CA114748-05S1
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-26
|
$11,261,801
|
$337,854
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
3P01CA084512-07S2
|
$200,000
|
$40,000
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Multiple Myeloma - Yale case-control
|
ZIA CP010123 02380
|
$164,762
|
$164,762
|
Baris, Dalsu
|
DCEG (NCI)
|
|
|
Multiple Myeloma BOAC study
|
ZIA CP010158 10523
|
$67,930
|
$67,930
|
Baris, Dalsu
|
DCEG (NCI)
|
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-16
|
$3,080,284
|
$3,080,284
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
|
Corn Farming Study
|
ZIA CP010119 02075
|
$109,185
|
$16,378
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-26
|
$1,751,531
|
$17,515
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
Cancer Center Support Grant
|
2P30CA042014-21
|
$1,483,602
|
$89,016
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
|
Cancer Center Support Grant
|
3P30CA042014-21S1
|
$99,413
|
$5,965
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-04
|
$499,869
|
$9,997
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
|
Iowa Oncology Research Association
|
5U10CA035101-25
|
$685,544
|
$6,855
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
|
ECOG Clinical Trials
|
2U10CA017145-35
|
$455,484
|
$18,219
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S2
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S4
|
$46,458
|
$929
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-46
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
2U10CA063844-17
|
$837,264
|
$8,373
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
3U10CA063844-17S1
|
$100,000
|
$1,000
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Molecular Pathogenesis of Multiple Myeloma
|
5R01CA133966-02
|
$332,000
|
$332,000
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
|
Comparative Pharmaco-oncogenomics of Myeloma Drug Resistance
|
5R01CA136671-02
|
$332,000
|
$332,000
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
|
Eastern Cooperative Oncology Group
|
2U10CA049957-22
|
$367,534
|
$14,701
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-27
|
$428,852
|
$4,289
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
|
Chaetocin as a Potential Therapy for Multiple Myeloma
|
5R01CA125750-03
|
$368,294
|
$368,294
|
BIBLE, KEITH
|
MAYO CLINIC
|
|
|
Energy Balance, IGF Dysregulation and Multiple Myeloma
|
5K07CA115687-05
|
$140,130
|
$140,130
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$183,397
|
$18,340
|
Bishop, Michael
|
CCR (NCI)
|
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$183,397
|
$18,340
|
Bishop, Michael
|
CCR (NCI)
|
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$244,529
|
$24,453
|
Bishop, Michael
|
CCR (NCI)
|
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
1U10CA142559-01
|
$188,304
|
$11,298
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$1,487,137
|
$74,357
|
Blumberg, Peter
|
CCR (NCI)
|
|
|
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress
|
5R01CA127910-04
|
$321,625
|
$321,625
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
|
Arsenic-induced apoptosis in myeloma
|
7R01CA129968-02
|
$387,826
|
$387,826
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
|
Selective Inhibition of HDAC6 in Cancer Therapy
|
5K08CA128972-03
|
$139,320
|
$139,320
|
BRADNER, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Breast implant follow-up study
|
ZIA CP010128 01220
|
$31,739
|
$1,587
|
Brinton, Louise
|
DCEG (NCI)
|
|
Total relevant funding to Multiple Myeloma for this search: $48,458,021
|
